Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium

Circulation Research

Volumn 117, Issue 7, 2015, Pages 634-644

  Weil, Brian R ^a   Suzuki, Gen ^a   Leiker, Merced M ^a   Fallavollita, James A ^a   Canty, John M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

bone marrow; cell and tissue based therapy; coronary stenosis; in situ hybridization, fluorescence; mesenchymal stromal cells; myocardial ischemia

Indexed keywords

CYCLOSPORIN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CARDIOSPHERE DERIVED CELL; CELL DENSITY; CELL FATE; CELLS BY BODY ANATOMY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DONOR; ENGRAFTMENT; FLUORESCENCE IN SITU HYBRIDIZATION; HEART MUSCLE; HISTOPATHOLOGY; INTRACORONARY ALLOGENEIC MESENCHYMAL STEM CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYMAL STEM CELL; MUSCLE CELL; NONHUMAN; PIG; PRIORITY JOURNAL; Y CHROMOSOME; ALLOTRANSPLANTATION; ANIMAL; CELL PROLIFERATION; CORONARY BLOOD VESSEL; HEART MUSCLE CELL; INTRAARTERIAL DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL STUNNING; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL PROLIFERATION; CORONARY VESSELS; INJECTIONS, INTRA-ARTERIAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL STUNNING; MYOCYTES, CARDIAC; SWINE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84941286878     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306850     Document Type: Article

References (45)

1. Simari RD, Pepine CJ, Traverse JH, Henry TD, Bolli R, Spoon DB, Yeh E, Hare JM, Schulman IH, Anderson RD, Lambert C, Sayre SL, Taylor DA, Ebert RF, Moyé LA. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network. Circ Res. 2014;114:1564-1568. doi: 10.1161/CIRCRESAHA.114.303720.
2. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126:551-568. doi: 10.1161/CIRCULATIONAHA.111.086074.
3. Marbán E, Malliaras K. Mixed results for bone marrow-derived cell therapy for ischemic heart disease. JAMA. 2012;308:2405-2406. doi: 10.1001/jama.2012.64751.
4. Gyöngyösi M, Wojakowski W, Lemarchand P, et al; ACCRUE Investigators. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116:1346-1360. doi: 10.1161/CIRCRESAHA.116.304346.
5. Couzin-Frankel J. The elusive heart fix. Science. 2014;345:252-257. doi: 10.1126/science.345.6194.252.
6. Jansen Of Lorkeers SJ, Eding JE, Vesterinen HM, van der Spoel TI, Sena ES, Duckers HJ, Doevendans PA, Macleod MR, Chamuleau SA. Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies. Circ Res. 2015;116:80-86. doi: 10.1161/CIRCRESAHA.116.304872
7. Jones SP, Tang XL, Guo Y, et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ Res. 2015;116:572-586. doi: 10.1161/CIRCRESAHA.116.305462.
8. Lefer DJ JS, Steenbergen C, Kukreja R, Guo Y, Tang X, Li Q, Ockaili R, Salloum F, Kong M, Polhemus DJ, Bhushan S, Goodchild T, Chang C, Book MJ, Du J, Bolli R. Sodium nitrite fails to limit myocardial infarct size: results from the CAESAR cardioprotection consortium. FASEB J. 2014;28:LB645.
9. Kukreja R TX, Lefer DJ, Steenbergen C, Jones S, Guo Y, Li Q, Kong M, Stowers H, Hunt G, Tokita Y, Wu W, Ockaili R, Salloum F, Book MJ, Du J, Bhushan S, Goodchild T, Chang C, Bolli R. Adminstration of sildenafil at reperfusion fails to reduce infarct size: results from the CAESAR cardioprotection consortium. FASEB J. 2014;28:LB650.
10. Heldman AW, DiFede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311:62-73. doi: 10.1001/jama.2013.282909.
11. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308:2369-2379. doi: 10.1001/jama.2012.25321.
12. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379:895-904. doi: 10.1016/S0140-6736(12)60195-0.
13. Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, Marbán L, Mendizabal A, Cingolani E, Johnston PV, Gerstenblith G, Schuleri KH, Lardo AC, Marbán E. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2014;63:110-122. doi: 10.1016/j.jacc.2013.08.724.
14. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA. 2009;106:14022-14027. doi: 10.1073/pnas.0903201106.
15. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010;107:913-922. doi: 10.1161/CIRCRESAHA.110.222703.
16. Suzuki G, Iyer V, Lee TC, Canty JM Jr. Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium. Circ Res. 2011;109:1044-1054. doi: 10.1161/CIRCRESAHA.111.245969.
17. Suzuki G, Weil BR, Leiker MM, Ribbeck AE, Young RF, Cimato TR, Canty JM Jr. Global intracoronary infusion of allogeneic cardiospherederived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium. PLoS One. 2014;9:e113009. doi: 10.1371/journal.pone.0113009.
18. Malliaras K, Smith RR, Kanazawa H, et al. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation. 2013;128:2764-2775. doi: 10.1161/CIRCULATIONAHA.113.002863.
19. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marbán E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115:896-908. doi: 10.1161/CIRCULATIONAHA.106.655209.
20. Fallavollita JA, Perry BJ, Canty JM Jr. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation. 1997;95:1900-1909.
21. Fallavollita JA, Logue M, Canty JM Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol. 2001;37:1989-1995.
22. Canty JM Jr, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA. Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death. Circ Res. 2004;94:1142-1149. doi: 10.1161/01. RES.0000125628.57672.CF.
23. Schimmel C, Frazer D, Glenny RW. Extending fluorescent microsphere methods for regional organ blood flow to 13 simultaneous colors. Am J Physiol Heart Circ Physiol. 2001;280:H2496-H2506.
24. Suzuki G, Iyer V, Cimato T, Canty JM Jr. Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ hematopoietic progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res. 2009 104:255-264.
25. Bruël A, Nyengaard JR. Design-based stereological estimation of the total number of cardiac myocytes in histological sections. Basic Res Cardiol. 2005;100:311-319. doi: 10.1007/s00395-005-0524-9.
26. Lim H, Fallavollita JA, Hard R, Kerr CW, Canty JM Jr. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation. 1999;100:2380-2386.
27. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marbán L, Marbán E. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiospherederived cells. J Am Coll Cardiol. 2012;59:942-953. doi: 10.1016/j. jacc.2011.11.029.
28. Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med. 2012;1:116-124. doi: 10.5966/sctm.2011-0015.
29. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013;127:213-223. doi: 10.1161/CIRCULATIONAHA.112.131110.
30. Dey D, Han L, Bauer M, Sanada F, Oikonomopoulos A, Hosoda T, Unno K, De Almeida P, Leri A, Wu JC. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res. 2013;112:1253-1262. doi: 10.1161/CIRCRESAHA.112.300779.
31. Malliaras K, Ibrahim A, Tseliou E, Liu W, Sun B, Middleton RC, Seinfeld J, Wang L, Sharifi BG, Marbán E. Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med. 2014;6:760-777. doi: 10.1002/emmm.201303626.
32. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med. 2013;5:191-209. doi: 10.1002/emmm.201201737.
33. Ibrahim AG, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2:606-619. doi: 10.1016/j.stemcr.2014.04.006.
34. Xie Y, Ibrahim A, Cheng K, Wu Z, Liang W, Malliaras K, Sun B, Liu W, Shen D, Cheol Cho H, Li T, Lu L, Lu G, Marbán E. Importance of cellcell contact in the therapeutic benefits of cardiosphere-derived cells. Stem Cells. 2014;32:2397-2406. doi: 10.1002/stem.1736.
35. Canty JM Jr, Suzuki G. Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease. J Mol Cell Cardiol. 2012;52:822-831. doi: 10.1016/j.yjmcc.2011.08.019.
36. Dorn GW II. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res. 2009;81:465-473. doi: 10.1093/cvr/cvn243.
37. Malliaras K, Li TS, Luthringer D, Terrovitis J, Cheng K, Chakravarty T, Galang G, Zhang Y, Schoenhoff F, Van Eyk J, Marbán L, Marbán E. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation. 2012;125:100-112. doi: 10.1161/CIRCULATIONAHA.111.042598.
38. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89:151-163.
39. Narula J, Dawson MS, Singh BK, Amanullah A, Acio ER, Chaudhry FA, Arani RB, Iskandrian AE. Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol. 2000;36:1913-1919.
40. Suzuki G, Weil BR, Leiker MM, Goelz A, Fallavollita JA, Canty JM Jr. Global intracoronary infusion of allogeneic cardiosphere-derived cells (CDCs) immediately after reperfusion stimulates myocyte regeneration in remote viable myocardium in swine with acute myocardial infarction. Circulation. 2014;130:A15656.
41. Suzuki G, Weil BR, Leiker MM, Canty J. Global intracoronary infusion of allogeneic atrial cardiosphere-derived cells (icCDCs) stimulates myocyte regeneration and reverses LV remodeling in miniature swine with chronic myocardial infarction.Global intracoronary infusion of allogeneic atrial cardiosphere-derived cells (icCDCs) stimulates myocyte regeneration and reverses LV remodeling in miniature swine with chronic myocardial infarction. Circulation. 2013;128:A9912.
42. Rosen MR, Myerburg RJ, Francis DP, Cole GD, Marbán E. Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol. 2014;64:922-937. doi: 10.1016/j. jacc.2014.06.1175.
43. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810-834. doi: 10.1161/CIRCRESAHA.113.300219.
44. Cheng K, Ibrahim A, Hensley MT, Shen D, Sun B, Middleton R, Liu W, Smith RR, Marbán E. Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction. J Am Heart Assoc. 2014;3:e001260. doi: 10.1161/JAHA.114.001260.
45. Page BJ, Banas MD, Suzuki G, Weil BR, Young RF, Fallavollita JA, Palka BA, Canty JM Jr. Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. J Am Coll Cardiol. 2015;65:684-697. doi: 10.1016/j. jacc.2014.11.040.